Molecular imaging of vessels in mouse models of disease

European Journal of Radiology

Volumn 70, Issue 2, 2009, Pages 305-311

  Zagorchev, Lyubomir ^a,b   Mulligan Kehoe, Mary J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

Angiogenesis; Extracellular matrix; Tumors

Indexed keywords

ANGIOGENESIS; ANIMAL MODELS; ARTERIOGENESIS; BASIC PRINCIPLES; BIOLOGICAL PROCESS; BIOLOGICAL VARIATIONS; EXTRACELLULAR MATRIX; IMAGING HARDWARES; IMAGING MODALITIES; MICRO-CT; MICRO-IMAGING; MICROPET; MOLECULAR IMAGING; MOUSE MODELS; MULTI MODALS; MULTIMODAL IMAGING; THREEDIMENSIONAL (3-D) STRUCTURES; TUMOR ANGIOGENESIS; VASCULAR IMAGING; VESSEL DEVELOPMENT; VOLUMETRIC DATUM;

COMPUTERIZED TOMOGRAPHY; DATA VISUALIZATION; IMAGE ANALYSIS; MODELS; ONCOLOGY; THREE DIMENSIONAL; TUMORS; ULTRASONIC APPLICATIONS; VOLUMETRIC ANALYSIS;

ULTRASONIC IMAGING;

CONTRAST MEDIUM;

ANGIOGENESIS; ARTICLE; CONFOCAL MICROSCOPY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE MODEL; ECHOGRAPHY; IMAGE ANALYSIS; IMAGING SYSTEM; MICRO COMPUTED TOMOGRAPHY; MICRO POSITRON EMISSION TOMOGRAPHY; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL;

ANGIOGRAPHY; ANIMALS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; HUMANS; MICE; MOLECULAR PROBE TECHNIQUES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 67349165057     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.01.053     Document Type: Article

References (71)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 46 February (2) (1986) 467-473
2. Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1 October (10) (1995) 1024-1028
3. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280 June (6) (2001) C1358-1366
4. Ferrara N., Chen H., Davis-Smyth T., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4 March (3) (1998) 336-340
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 January (1) (1995) 27-31
6. Davis G.E., Bayless K.J., and Mavila A. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 268 November (3) (2002) 252-275
7. Senger D.R. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 149 July (1) (1996) 1-7
8. Stupack D.G., and Cheresh D.A. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 22 December (56) (2003) 9022-9029
9. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 3 November (7) (2003) 643-651
10. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 January (4787) (1987) 442-447
11. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 August (3) (1996) 353-364
12. Cao Y., Ji R.W., Davidson D., et al. Kringle domains of human angiostatin Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 271 November (46) (1996) 29461-29467
13. Colorado P.C., Torre A., Kamphaus G., et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60 May (9) (2000) 2520-2526
14. Kamphaus G.D., Colorado P.C., Panka D.J., et al. a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275 January (2) (2000) 1209-1215
15. Maeshima Y., Sudhakar A., Lively J.C., et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295 January (5552) (2002) 140-143
16. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 January (2) (1997) 277-285
17. Sasaki T., Larsson H., Tisi D., Claesson-Welsh L., Hohenester E., and Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol 301 September (5) (2000) 1179-1190
18. Staton C.A., Brown N.J., Rodgers G.R., et al. a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood 103 January (2) (2004) 601-606
19. Durand M.K., Bodker J.S., Christensen A., et al. Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb Haemost 91 March (3) (2004) 438-449
20. Lijnen H.R. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 3 January (1) (2005) 35-45
21. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21 July (7) (2001) 1104-1117
22. Drinane M., Walsh J., Mollmark J., Simons M., and Mulligan-Kehoe M.J. The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions. J Biol Chem 281 November (44) (2006) 33336-33344
23. Mulligan-Kehoe M.J., Wagner R., Wieland C., and Powell R. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. J Biol Chem 276 March (11) (2001) 8588-8596
24. Bushberg J., Seibert J., Leidholdt E., and Boone J. The essential physics of medical imaging. 2nd ed. (2002), Lippencott, Williams and Wilkins
25. Wolbarst A. Physics of radiology. 2nd ed. (2005), Medical Physics Publishing, Madison Wisconsin
26. Bouxsein M.L., Uchiyama T., Rosen C.J., et al. Mapping quantitative trait loci for vertebral trabecular bone volume fraction and microarchitecture in mice. J Bone Miner Res 19 April (4) (2004) 587-599
27. Engelke K., Karolczak M., Lutz A., Seibert U., Schaller S., and Kalender W. Micro-CT. Technology and application for assessing bone structure. Der Radiologe 39 March (3) (1999) 203-212
28. Graichen H., Lochmuller E.M., Wolf E., et al. A non-destructive technique for 3-D microstructural phenotypic characterisation of bones in genetically altered mice: preliminary data in growth hormone transgenic animals and normal controls. Anat Embryol 199 March (3) (1999) 239-248
29. Halloran B.P., Ferguson V.L., Simske S.J., Burghardt A., Venton L.L., and Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res 17 June (6) (2002) 1044-1050
30. Pugener L.A., and Maglia A.M. Skeletal morphogenesis of the vertebral column of the miniature hylid frog Acris crepitans, with comments on anomalies. J Morphol October (2008)
31. Rubin C., Turner A.S., Muller R., et al. Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. J Bone Miner Res 17 February (2) (2002) 349-357
32. Paulus M.J., Gleason S.S., Kennel S.J., Hunsicker P.R., and Johnson D.K. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia (New York, N.Y.) 2 January-April (1-2) (2000) 62-70
33. Pickhardt P.J., Halberg R.B., Taylor A.J., et al. Microcomputed tomography colonography for polyp detection in an in vivo mouse tumor model. Proc Natl Acad Sci USA 102 March (9) (2005) 3419-3422
34. Marxen M., Thornton M.M., Chiarot C.B., et al. MicroCT scanner performance and considerations for vascular specimen imaging. Med Phys 31 February (2) (2004) 305-313
35. Jensen M.M., Jorgensen J.T., Binderup T., and Kjaer A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med Imaging 8 (2008) 16
36. Kennel S.J., Davis I.A., Branning J., Pan H., Kabalka G.W., and Paulus M.J. High resolution computed tomography and MRI for monitoring lung tumor growth in mice undergoing radioimmunotherapy: correlation with histology. Med Phys 27 May (5) (2000) 1101-1107
37. Gruber H.E., Ashraf N., Kilburn J., et al. Vertebral endplate architecture and vascularization: application of micro-computerized tomography, a vascular tracer, and immunocytochemistry in analyses of disc degeneration in the aging sand rat. Spine 30 December (23) (2005) 2593-2600
38. Wirkner C.S., and Prendini L. Comparative morphology of the hemolymph vascular system in scorpions-a survey using corrosion casting, MicroCT, and 3D-reconstruction. J Morphol 268 May (5) (2007) 401-413
39. Clauss S.B., Walker D.L., Kirby M.L., Schimel D., and Lo C.W. Patterning of coronary arteries in wildtype and connexin43 knockout mice. Dev Dyn 235 October (10) (2006) 2786-2794
40. Widmann G., Riedl A., Schoepf D., Glodny B., Peer S., and Gruber H. State-of-the-art HR-US imaging findings of the most frequent musculoskeletal soft-tissue tumors. Skelet Radiol October (2008)
41. Cheung A.M., Brown A.S., Cucevic V., et al. Detecting vascular changes in tumour xenografts using micro-ultrasound and micro-ct following treatment with VEGFR-2 blocking antibodies. Ultrasound Med Biol 33 August (8) (2007) 1259-1268
42. Flais S., Lassau N., and Leclere J. [Tumor vascularization: contribution of Doppler ultrasonography]. J Radiol 77 December (12) (1996) 1207-1212
43. Kaushik S., Miller T.T., Nazarian L.N., and Foster W.C. Spectral Doppler sonography of musculoskeletal soft tissue masses. J Ultrasound Med 22 December (12) (2003) 1333-1336
44. Schroeder R.J., Hauff P., Bartels T., et al. Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. Ultrasound Med Biol 27 June (6) (2001) 761-771
45. Calliada F., Campani R., Bottinelli O., Bozzini A., and Sommaruga M.G. Ultrasound contrast agents: basic principles. Eur J Radiol 27 May (Suppl. 2) (1998) S157-160
46. Feleppa E.J., Alam S.K., and Deng C.X. Emerging ultrasound technologies for early markers of disease. Dis Markers 18 5-6 (2002) 249-268
47. McQuade P., Knight L.C., and Welch M.J. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis. Bioconjug Chem 15 September-October (5) (2004) 988-996
48. Wang H., Cai W., Chen K., et al. A new PET tracer specific for vascular endothelial growth factor receptor 2. Eur J Nucl Med Mol Imaging 34 December (12) (2007) 2001-2010
49. Wu Y., Zhang X., Xiong Z., et al. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med 46 October (10) (2005) 1707-1718
50. Cherry S.R., Shaol Y., Silverman R.W., et al. A high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci 44 3 (1997) 1161-1166
51. Chen J.C., Chang S.M., Hsu F.Y., Wang H.E., and Liu R.S. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma. Appl Radiat Isot 61 November (5) (2004) 887-891
52. Chen X., Park R., Hou Y., et al. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur J Nucl Med Mol imaging 31 August (8) (2004) 1081-1089
53. Wu A.M., Yazaki P.J., Tsai S., et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci USA 97 July (15) (2000) 8495-8500
54. Zhang X., Xiong Z., Wu Y., et al. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 47 January (1) (2006) 113-121
55. Wu Y., Zhong Z., Huber J., et al. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer. Clin Cancer Res 12 November (21) (2006) 6573-6584
56. Zhu Z., Hattori K., Zhang H., et al. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2 Correlation between antibody affinity and biological activity. Leukemia 17 March (3) (2003) 604-611
57. Zhu Z., Rockwell P., Lu D., et al. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. Cancer Res 58 August (15) (1998) 3209-3214
58. Delbaldo C., Raymond E., Vera K., et al. and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. Invest New Drugs 26 February (1) (2008) 35-43
59. Gutheil J.C., Campbell T.N., Pierce P.R., et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. Clin Cancer Res 6 August (8) (2000) 3056-3061
60. McNeel D.G., Eickhoff J., Lee F.T., et al. trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res 11 November (21) (2005) 7851-7860
61. Cai W., Wu Y., Chen K., Cao Q., Tice D.A., and Chen X. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. Cancer Res 66 October (19) (2006) 9673-9681
62. Zimmermann K., Grunberg J., Honer M., Ametamey S., Schubiger P.A., and Novak-Hofer I. Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging. Nucl Med Biol 30 May (4) (2003) 417-427
63. Logan T.F., Jadali F., Egorin M.J., et al. Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial. Cancer Chemother Pharmacol 50 December (6) (2002) 433-444
64. Schmidt K.C., and Turkheimer F.E. Kinetic modeling in positron emission tomography. Q J Nucl Med 46 March (1) (2002) 70-85
65. Backer M.V., Levashova Z., Patel V., et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat Med 13 April (4) (2007) 504-509
66. Guo L., Burke P., Lo S.H., Gandour-Edwards R., and Lau D. Quantitative analysis of angiogenesis using confocal laser scanning microscopy. Angiogenesis 4 3 (2001) 187-191
67. Inai T., Mancuso M., Hashizume H., et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165 July (1) (2004) 35-52
68. Hajnal J., Hill D., and Hawkes D. Medical image registration (2001), CRC Press
69. Zagorchev L., and Goshtasby A. A Comparative study of transformation functions for nonrigid image registration. IEEE Trans Image Process 15 3 (2006)
70. Zitova B., and Flusser J. Image registration methods: a survey. Image Vis Comput 21 (2003) 977-1000
71. Goshtasby A. 2D and 3D image registration: for medical, remote sensing, and industrial applications (2005), Wiley-Interscience